Novel drug approvals using expedited programs
STO-REC-STATE42Q7GT1 Official
33
United States · 2024
Novel drug approvals using expedited programs in United States stood at 33 in 2024 (FDA).
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- CDER’s Effectiveness Bringing New Therapies to Market
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Expedited Programs: In 2024, CDER approved 33 of the 50 new therapies (66%) using one or more expedited approval programs: fast track designation, breakthrough therapy designation, priority review designation, and Accelerated Approval.
Verbatim extraction verified: The figure 33 is directly attested in the quoted passage (CDER’s Effectiveness Bringing New Therapies to Market).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2
- MLA
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2.
- Chicago
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2.
- BibTeX
- @misc{fda2024novel238ec2, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_E42Q7GDFNTTE16PB42TN238EC2}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
- Type
- Press release
- Published
- —
- Locator
- CDER’s Effectiveness Bringing New Therapies to Market
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_E42Q7GDFNTTE16PB42TN238EC2